Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.
Citação norma ChicagoHorton, C., TJ Davies, P. Lahiri, P. Sachamitr, and PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
Citação norma MLAHorton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.